Quantcast
Channel: WN.com - Articles related to Preclinical Data of Xencor's XmAb Bispecific Technology to be Presented at Upcoming ASH Annual Meeting
Viewing all articles
Browse latest Browse all 614

Xencor's (XNCR) CEO Bassil Dahiyat on Q4 2016 Results - Earnings Call Transcript

$
0
0
Xencor, Inc. (NASDAQ:XNCR) Q4 2016 Earnings Conference Call February 28, 2017, 04:30 PM ET Executives Hannah Deresiewicz - Stern Investor Relations Bassil Dahiyat - President, Chief Executive Officer and Director Paul Foster - Chief Medical Officer. John Kuch - Vice President, Finance Analysts Michael Schmidt - Leerink Partners Arlinda Lee - Canaccord Genuity Operator Good day, ladies and gentlemen, and welcome to the Xencor Incorporated Q4 2016 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to introduce your host for...

Viewing all articles
Browse latest Browse all 614

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>